Needle Free Drug Delivery Devices Market Scope And Analysis

  • Report Code : TIPHE100001168
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Needle-Free Drug Delivery Devices Market Analysis and Scope (2024 to 2031)

Buy Now


Needle-Free Drug Delivery Devices Market Report Scope

Report Attribute Details
Market size in 2023 US$ 14.76 Billion
Market Size by 2031 US$ 28.42 Billion
Global CAGR (2023 - 2031) 8.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Inhalers
  • Jet Injectors
  • Novel Needles
  • Transdermal Patches
By Application
  • Insulin Delivery
  • Vaccination
  • Pain Management
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • NuGen Medical Devices Inc
  • NovaXS Biotech
  • GlaxoSmithKline
  • AstraZeneca
  • Roche
  • Boehringer Ingelheim
  • Merck
  • Cipla
  • Novartis
  • Teva Pharmaceuticals
  • Needle-Free Drug Delivery Devices Market Report Coverage and Deliverables

    The “Needle-Free Drug Delivery Devices Market Size and Forecast (2023–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles